Skip to content
Riskpilot
← Back to search
Sign in
Get full access
DeltaG Biotech AB
AB
Active
Org 5594336116
Korshamnsvägen 59, 475 40
Hönö
Business and other management consultancy activities
· NACE 7020
Est. 2023
0 employees
Watchlist
Share
Sweden
/
Companies
/
Business and other management consultancy activities
/
DeltaG Biotech AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
0M
1M
1M
1M
0M
2023
1M
2024
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2023
1M
2024
Income statement
SEK thousands
Item
2023
2024
Revenue
228
850
Staff expenses
—
—
EBITDA
216
826
Depreciation & amort.
−0
−0
EBIT
216
826
Net financials
3
10
Profit before tax
218
836
Tax
−45
−172
Net profit
173
664
Balance sheet
SEK thousands
Item
2023
2024
Total assets
304
814
Equity
259
689
Long-term debt
0
0
Short-term debt
45
125
Total debt
45
125
Financial ratios
5-year trend
EBITDA margin
97.2%
This company
15.8%
Market median
+515% vs market
2023
2024
Equity ratio
84.6%
This company
38.2%
Market median
+121% vs market
2023
2024
Return on equity
96.4%
This company
18.4%
Market median
+424% vs market
2023
2024
Net profit margin
78.1%
This company
8.1%
Market median
+864% vs market
2023
2024
Asset turnover
1.04×
This company
1.12×
Market median
+7% vs market
2023
2024
Debt / equity
0.18×
This company
0.62×
Market median
+71% vs market
2023
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-05-01 – 2023-12-31
View
PDF
More on DeltaG Biotech AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
